Bait Al Batterjee Pharmaceutical Industries

Name

Bait Al Batterjee Pharmaceutical Industries

Website

https://babpharma.com

Company type

Private

Founded year

2008

Headcount range

101–250 employees

Short description

Bait Al Batterjee Pharmaceutical Industries is a privately held pharmaceutical supplier based in Jeddah, Saudi Arabia, founded in 2008 and led by founder and CEO Rudwan Batterjee. The company employs 101-250 staff serving the Saudi Arabian pharmaceutical market.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industry

Controlled Substances / DEA-Scheduled API Manufacturing (HLAGAHAD)

Keywords

• Pharmaceutical manufacturing
• Pharmaceutical supply
• Drug products
• Pharmaceutical distribution
• Finished dosage forms

Headquarters

HQ city

Jeddah

HQ country

Saudi Arabia

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel

Core offering

Bait Al Batterjee Pharmaceutical Industries is a Jeddah-headquartered pharmaceutical company founded in 2008 that supplies pharmaceutical products. It operates as a for-profit private company with 101–250 employees. Specific therapeutic categories, dosage forms, and product details are not available in the source material.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Regional players

• EIPICO (Egyptian International Pharmaceutical Industries): One of the largest pharma manufacturers in the Arab world, exporting generics to Saudi Arabia and other GCC states. Comparable as a regional peer supplying similar product categories into the Saudi market.
• EVA Pharma: Major Egyptian pharmaceutical manufacturer exporting across the MENA region. Comparable as a regional generics supplier competing for the same tender and distribution channels that Bait Al Batterjee serves.

Broad incumbents

• Hikma Pharmaceuticals: Leading MENA-headquartered multinational generics manufacturer with significant Saudi market presence. Comparable as a broader pharma supplier competing for Saudi institutional and retail generics contracts.
• SPIMACO Addwaeih: Saudi Arabia's largest publicly listed pharmaceutical manufacturer and distributor. Directly comparable as a Jeddah-region pharma supplier serving Saudi hospitals, pharmacies, and government tenders with branded generics and consumer health products.
• Julphar (Gulf Pharmaceutical Industries): One of the largest pharmaceutical manufacturers in the Middle East, headquartered in the UAE with broad GCC distribution. Comparable as a regional pharma supplier targeting government tenders and private-label generics across the same end markets.
• Aurobindo Pharma (Saudi operations): Global generics major with active manufacturing and supply operations in Saudi Arabia. Comparable as a competing supplier of generic pharmaceuticals to Saudi public and private healthcare buyers.

Direct peers

• Jamjoom Pharma: Saudi-based pharmaceutical company manufacturing and marketing branded generics across the GCC. Directly comparable as a privately-held Saudi pharma supplier with overlapping product, channel, and customer profile.
• Al-Dawaa Medical Services Company: Saudi-headquartered pharmaceutical retail and distribution platform operating across the Kingdom. Comparable as a Saudi pharma distribution and supply counterpart that channels finished products to end buyers.
• Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO subsidiary Al-Taqaddom): SPIMACO-aligned local manufacturing peers serving Saudi health authorities; comparable as a domestic finished-dose supplier in the same Jeddah/western-region distribution catchment.
• Tabuk Pharmaceuticals Manufacturing Company: Leading Saudi pharmaceutical manufacturer focused on branded generics and licensing partnerships with multinational innovators. Highly comparable business model: local manufacturing supplying Saudi and regional markets.

Market position

Customer concentration

• LinkedInlinkedin.com/company/babpharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bait Al Batterjee Pharmaceutical Industries